Genova Diagnostics acquires Metametrix

Wednesday, July 11, 2012 09:17 AM

Genova Diagnostics, a global specialty clinical laboratory based in Asheville, N.C., has decided to acquire Metametrix, a clinical laboratory in Duluth, Ga.

Genova purchased all assets of Metametrix and will continue to operate under both brands at this time. The combined entity will provide a broader range of testing services, as well as increase the breadth of support and resources dedicated to physicians and their patients.

"We share a mission of improving the health of patients worldwide by striving to be the best provider of comprehensive and innovative clinical laboratory services,” said J. Alexander Bralley, CEO of Metametrix. Bralley will continue working in a consulting capacity in the newly aligned organization, focusing on development of next-generation testing approaches and clinical education programs.

"Consolidating our companies significantly increases our global presence,” said Ted Hull, chairman and CEO of Genova Diagnostics. “Together, we serve over 9,000 healthcare practitioners annually throughout the United States and internationally in 45 countries with our 400 employees and three locations in Asheville, N.C., Duluth, Ga., and London, England. Our combined resources will allow us to expand investments in research & development, clinical trials, medical education and market expansion.”

Financial terms of the transaction were not disclosed.

Share:          
CWWeekly

February 23

Venture capital investors funding novel drug R&D three times more than companies repurposing, improving existing drugs

In appreciation: Karen Woodin will be remembered for her teaching, writing and lasting friendships

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs